ALEXANDRIA, Va., Dec. 31 -- United States Patent no. 12,510,535, issued on Dec. 30, was assigned to Amberstone Biosciences Inc. (Laguna Hills, Calif.).
"Compartmentalized assays of bispecific and multispecific biologics" was invented by George Guikai Wu (Laguna Hills, Calif.) and Yonglei Shang (Laguna Hills, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "A method for performing assays in compartmentalized nano-volumes to screen for functional bispecific or multispecific biologics, including: obtaining a plurality of at least two distinct types of cells, wherein a first-type of cells are engineered to express a single genetic-variant per cell of a bispecific or multispecific biologic in a secreted form...